SCHEMBL6997153

SCHEMBL6997153

CSc1cc2c(cc1[N+](=O)[O-])OC(C)C(N)=N2

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPT P10636 4/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
POLB P06746 1/20 0.33
MCL1 Q07820 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
P2RY6 Q15077 1/20 0.30
KDM4E B2RXH2 1/20 0.30
G6PD P11413 1/20 0.30
PKM P14618 1/20 0.30
MAPK1 P28482 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
APOBEC3G Q9HC16 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7000231 0.80 TDP1 (0.36) CYP1A2CYP2C9CYP2C19MAPTMEN1
SCHEMBL6991149 0.73 NOS3 (0.48) MAPTMEN1KMT2AP2RY6
SCHEMBL7000074 0.69 TDP1 (0.43) MAPTMEN1KMT2AL3MBTL1P2RY6
SCHEMBL5670575 0.68 ESR1 (0.35)
SCHEMBL8129131 0.68 GRIK1 (0.43) MAPT
SCHEMBL8837286 0.65 MAPT (0.57) CYP1A2CYP2C9CYP2C19MAPTMEN1
SCHEMBL8444670 0.65 TDP1 (0.47) CYP1A2MAPTMEN1KMT2APOLB
SCHEMBL8447032 0.64 SLC6A4 (0.53) MAPTMEN1KMT2A
SCHEMBL6993506 0.63 KDM4E (0.34) MAPTMEN1KMT2AL3MBTL1KDM4E
SCHEMBL7710726 0.63 ALDH1A1 (0.45) MAPTMEN1KMT2APOLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed